Spyre Therapeutics Insider Sold Shares Worth $5,952,050, According to a Recent SEC Filing
Michael Thomas Henderson, Director, on May 08, 2026, sold 80,000 shares in Spyre Therapeutics (SYRE) for $5,952,050. Following the Form 4 filing with the SEC, Henderson has control over a total of 88,606 common shares of the company, with 88,606 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1636282/000163628226000053/xslF345X05/wk-form4_1778290306.xml